Literature DB >> 8812419

Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13.

F J Couch1, J M Rommens, S L Neuhausen, C Bélanger, M Dumont, K Abel, R Bell, S Berry, R Bogden, L Cannon-Albright, L Farid, C Frye, T Hattier, T Janecki, P Jiang, R Kehrer, J F Leblanc, J McArthur-Morrison, D Meney, Y Miki, Y Peng, C Samson, M Schroeder, S C Snyder, J Simard.   

Abstract

An integrated approach involving physical mapping, identification of transcribed sequences, and computational analysis of genomic sequence was used to generate a detailed transcription map of the 1. 0-Mb region containing the breast cancer susceptibility locus BRCA2 on chromosome 13q12-q13. This region is included in the genetic interval bounded by D13S1444 and D13S310. Retrieved sequences from exon amplification or hybrid selection procedures were grouped into physical intervals and subsequently grouped into transcription units by clone overlap. Overlap was established by direct hybridization, cDNA library screening, PCR cDNA linking (island hopping), and/or sequence alignment. Extensive genomic sequencing was performed in an effort to understand transcription unit organization. In total, approximately 500 kb of genomic sequence was completed. The transcription units were further characterized by hybridization to RNA from a series of human tissues. Evidence for seven genes, two putative pseudogenes, and nine additional putative transcription units was obtained. One of the transcription units was recently identified as BRCA2 but all others are novel genes of unknown function as only limited alignment to sequences in public databases was observed. One large gene with a transcript size of 10.7 kb showed significant similarity to a gene predicted by the Caenorhabditis elegans genome and the Saccharomyces cerevisiae genome sequencing efforts, while another contained a motif sequence similar to the human 2',3' cyclic nucleotide 3' phosphodiesterase gene. Several retrieved transcribed sequences were not aligned into transcription units because no corresponding cDNAs were obtained when screening libraries or because of a lack of definitive evidence for splicing signals or putative coding sequence based on computational analysis. However, the presence of additional genes in the BRCA2 interval is suggested as groups of putative exons and hybrid selected clones that were transcribed in consistent orientations could be localized to common physical intervals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8812419     DOI: 10.1006/geno.1996.0428

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  An assessment of gene prediction accuracy in large DNA sequences.

Authors:  R Guigó; P Agarwal; J F Abril; M Burset; J W Fickett
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

2.  A complexity reduction algorithm for analysis and annotation of large genomic sequences.

Authors:  Trees-Juen Chuang; Wen-Chang Lin; Hurng-Chun Lee; Chi-Wei Wang; Keh-Lin Hsiao; Zi-Hao Wang; Danny Shieh; Simon C Lin; Lan-Yang Ch'ang
Journal:  Genome Res       Date:  2003-02       Impact factor: 9.043

3.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Authors:  S L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; J Garber; D Stoppa-Lyonnet; E Olah; B Csokay; O Serova; F Lalloo; A Osorio; M Stratton; K Offit; J Boyd; M A Caligo; R J Scott; A Schofield; E Teugels; M Schwab; L Cannon-Albright; T Bishop; D Easton; J Benitez; M C King; B A Ponder; B Weber; P Devilee; A Borg; S A Narod; D Goldgar
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  A genetic screen to identify components of the sina signaling pathway in Drosophila eye development.

Authors:  T P Neufeld; A H Tang; G M Rubin
Journal:  Genetics       Date:  1998-01       Impact factor: 4.562

5.  A low proportion of BRCA2 mutations in Finnish breast cancer families.

Authors:  P Vehmanen; L S Friedman; H Eerola; L Sarantaus; S Pyrhönen; B A Ponder; T Muhonen; H Nevanlinna
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

Review 6.  Genomic Biomarkers for Breast Cancer Risk.

Authors:  Michael F Walsh; Katherine L Nathanson; Fergus J Couch; Kenneth Offit
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  Mammalian actin-related protein 2/3 complex localizes to regions of lamellipodial protrusion and is composed of evolutionarily conserved proteins.

Authors:  L M Machesky; E Reeves; F Wientjes; F J Mattheyse; A Grogan; N F Totty; A L Burlingame; J J Hsuan; A W Segal
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

8.  Pag1p, a novel protein associated with protein kinase Cbk1p, is required for cell morphogenesis and proliferation in Saccharomyces cerevisiae.

Authors:  Li-Lin Du; Peter Novick
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

9.  Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Authors:  P N Tonin; A M Mes-Masson; P A Futreal; K Morgan; M Mahon; W D Foulkes; D E Cole; D Provencher; P Ghadirian; S A Narod
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

10.  Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.

Authors:  Kathleen K Oros; Guy Leblanc; Suzanna L Arcand; Zhen Shen; Chantal Perret; Anne-Marie Mes-Masson; William D Foulkes; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Journal:  BMC Med Genet       Date:  2006-03-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.